CN Patent

CN103429585B — 作为白细胞介素-1受体相关激酶抑制剂的吲唑基三唑衍生物

Assigned to Merck Serono SA · Expires 2015-07-08 · 11y expired

What this patent protects

式(I)的化合物涉及用于治疗炎症和自身免疫性疾病。

USPTO Abstract

式(I)的化合物涉及用于治疗炎症和自身免疫性疾病。

Drugs covered by this patent

gilteritinib-fumarate (GILTERITINIB FUMARATE)

Patent Metadata

Patent number: CN103429585B
Jurisdiction: CN
Classification: —
Expires: 2015-07-08
Drug substance claim: No
Drug product claim: No
Assignee: Merck Serono SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.